0001209191-22-002285.txt : 20220106
0001209191-22-002285.hdr.sgml : 20220106
20220106205704
ACCESSION NUMBER: 0001209191-22-002285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220104
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERMAN JEFFREY W
CENTRAL INDEX KEY: 0001230482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 22516299
MAIL ADDRESS:
STREET 1: C/O IDM PHARMA, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-04
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001230482
SHERMAN JEFFREY W
C/O HORIZON THERAPEUTICS PLC,
70 SAINT STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
0
1
0
0
EVP and Chief Medical Officer
Ordinary Shares
2021-11-08
5
G
0
E
10729
0.00
D
9115
D
Ordinary Shares
2021-11-08
5
G
0
E
10729
0.00
A
37808
I
See footnote
Ordinary Shares
2021-12-13
5
G
0
E
50
0.00
D
37758
I
See footnote
Ordinary Shares
2022-01-05
4
M
0
52570
A
61685
D
Ordinary Shares
2022-01-05
4
A
0
32301
0.00
A
93986
D
Ordinary Shares
2022-01-05
4
F
0
37675
0.00
D
56311
D
Ordinary Shares
105808
I
See footnote
Ordinary Shares
66730
I
By spouse
Restricted Stock Units (RSU)
2022-01-04
4
A
0
19044
0.00
A
Ordinary Shares
19044
19044
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
12261
0.00
D
Ordinary Shares
12261
0
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
12095
0.00
D
Ordinary Shares
12095
12095
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
9222
0.00
D
Ordinary Shares
9222
9223
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
9678
0.00
D
Ordinary Shares
9678
4834
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
9314
0.00
D
Ordinary Shares
9314
18628
D
The shares are held in the Jeffrey W. Sherman Living Trust.
Each RSU represents a contingent right to receive one ordinary share of the Issuer.
On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above.
The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2022.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023.
Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.
/s/ Miles W. McHugh, Attorney-in-Fact
2022-01-06